We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Information on taking, submitting and processing samples which potentially contain monkeypox virus.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Information on cryptosporidium including sources and routes of transmission, symptoms, and general hygiene advice to minimise the spread.
This article relates to improving available drugs for the treatment of Chagas disease
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Check what side effects people have reported when they've taken a medicine.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).